Her treatment is complicated by high costs and insurance constraints, which have affected her ability to consistently access ...

Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.

A recent study published in CHEST found that treatment-naïve adults with obesity-hypoventilation syndrome receiving a combination of acetazolamide and atomoxetine for 2 weeks had improved ...

Biologics represent a breakthrough in the management of airway diseases, offering precision treatments that target specific immune pathways. This special issue, Biologics for Airway Diseases: From ...

Nearly 30 million adults in the U.S. have obstructive sleep apnea (OSA)-and many don't even know it. If you've been waking up ...

Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) Annual Scientific Session and Expo in New Orleans, March 28 to 30. The ...

Patients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary ...

AllRock Bio, Inc., a clinical-stage biotechnology company focused on advancing impactful therapies for cardiopulmonary and ...

In a phase 2 trial, treatment with sotatercept shows reduced pulmonary vascular resistance and heart outcomes in patients ...

Select your location to view local American Lung Association events and news near you.

Pulmonary embolism, or PE, is a serious and sometimes life-threatening condition that occurs when a blood clot travels to the ...

Once the reality set in that my sister was cancer-free and in remission, I realized I was unprepared for what life would look ...